Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations.
van Laar
Teus
T
Postma
Anna G
AG
Drent
Martje
M
D000368:Aged; D000704:Analysis of Variance; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001058:Apomorphine / Q000627:therapeutic use*; D004294:Domperidone / Q000627:therapeutic use; D005260:Female; D006212:Hallucinations / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D055104:Infusions, Subcutaneous / Q000379:methods*; D008297:Male; D008609:Mental Status Schedule; D008875:Middle Aged; D009483:Neuropsychological Tests; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D011446:Prospective Studies; D012720:Severity of Illness Index
D000978:Antiparkinson Agents; D004294:Domperidone; D001058:Apomorphine